1-20 of 734
survival curve
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Natural History of Tumor Thrombus: A Single-Centre Retrospective Study

Free
Curtis Marcoux, MD MSc, Shahad Al Ghamdi, MD, Daria Manos, MD, Mary-Margaret Keating, MD, Sudeep P Shivakumar, MD BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2430.
https://doi.org/10.1182/blood-2019-124476
Published: 2019
Journal Articles

Mn Porphyrin-Based Redox Active Drugs Improve Anemia and Reduce Organ Damage in a Murine Model of Sickle Cell Disease

Free
Madhan Thamilarasan, PhD, Rodolfo Estupinan, Rahima Zennadi, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2255.
https://doi.org/10.1182/blood-2019-131140
Published: 2019
Journal Articles

Cardiac Injury and Microvascular Ischemia in Sickle Cell Disease

Free
Kiranveer Kaur, Ying Huang, MS, MA, Subha Raman, MD MS, Eric H. Kraut, MD, Payal Desai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2286.
https://doi.org/10.1182/blood-2019-125445
Published: 2019
Journal Articles

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Free
Elena E. Solomou, MD, Alexandra Kourakli, MD PhD, Anna Vardi, MD PhD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, MD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Aikaterini Palla, Athina Vyniou, Charalampos Pontikoglou, MD PhD, Panagiotis T Diamantopoulos, MD PhD, Theodoros Vassilakopoulos, MD, Aikaterini Megalakaki, Eleni Variami, Helen A. Papadaki, MD PhD, George Vassilopoulos, MD PhD, Achilles Anagnostopoulos, Argiris Symeonidis, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5417.
https://doi.org/10.1182/blood-2019-131003
Published: 2019
Journal Articles

Clinical Validation of the Myelofibrosis Transplant Scoring System in an Independent Series of Myelofibrosis Patients Undergoing Allogeneic Hematopoietic Transplantation

Free
Juan-Gonzalo Correa, Rosalía de la Puerta, Ana Benzaquen, Jorge Mora, Ana A. Martín, MD, Nieves Dorado, MD, María Laura Fox, Adolfo Saez-Martin, MD, Montserrat Rovira, Elvira Mora Castera, MD, Rafael Hernani, Albert Esquirol, Ignacio Gómez-Centurión, MD, Veronica Aguilar-Perea, Valentin Garcia Gutierrez, MD PhD, Santiago Osorio-Prendes, MD, Fermin Sanchez-Guijo, MD PhD, Irene García-Cadenas, Jose Luis Pinana, Alberto Alvarez-Larrán, MD PhD, Rodrigo Martino, MD PhD, Carlos Solano, MD PhD, Francisco Cervantes, Juan Carlos Hernandez Boluda
Journal: Blood
Blood (2019) 134 (Supplement_1): 5733.
https://doi.org/10.1182/blood-2019-126036
Published: 2019
Journal Articles

KIR-Genotype Mismatch, Donor KIR Locus 3DS1 Positive or 2DS3 Negative Facilitates a Positive Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study of 74 Patients

Free
Yu Zhang, Shaozhen Chen, Jinhua Ren, Xiaofeng Luo, Jianda Hu, PhD, Ting Yang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5736.
https://doi.org/10.1182/blood-2019-127819
Published: 2019
Journal Articles

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Free
Thomas G. Knight, MD, Myra Robinson, MS, Jing Ai, MD PhD, Brittany K Ragon, MD, Rhonda Davis, RN, BSN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Hailey Glover, RN, BSN, Jigar Trivedi, MSc, PharmD, Belinda R Avalos, MD, Jonathan M. Gerber, MD, James T Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2099.
https://doi.org/10.1182/blood-2019-128858
Published: 2019
Journal Articles

Characteristics and Outcomes of Therapy-Related Versus De Novo Acute Myeloid Leukemia with Normal Karyotype

Free
Bachar Samra, MD, Guillaume Richard-Carpentier, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Veronica A Guerra, MD, Naval G. Daver, MD, Courtney D. DiNardo, MDMSc, Ghayas C. Issa, MD, Prithviraj Bose, MD, Musa Yilmaz, MD, Maro Ohanian, DO, Gautam M. Borthakur, MD, Guillermo Garcia-Manero, MD, Sherry A. Pierce, BSN, BA, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3834.
https://doi.org/10.1182/blood-2019-125330
Published: 2019
Journal Articles

Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab

Free
Talha Badar, MD, Aniko Szabo, PhD, Anjali S. Advani, MD, Martha Wadleigh, MD, Shukaib Arslan, MD, Muhammad Khan, Ibrahim Aldoss, MD, Caitlin Siebenaller, PharmD, Elizabeth Schultz, Mehrdad Hefazi, MD, Rory M Shallis, MD, Ilana Yurkiewicz, MD BS, Nikolai A. Podoltsev, MD PhD, Anand Ashwin Patel, MD, Emily K Curran, MD, Suresh Kumar Balasubramanian, MD, Jay Yang, MD, Ryan J. Mattison, MD, Madelyn Burkart, MD, Shira Dinner, Michaela Liedtke, MD, Mark Litzow, MD, Ehab L. Atallah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3809.
https://doi.org/10.1182/blood-2019-125466
Published: 2019
Journal Articles

Acute Undifferentiated Leukemia

Free
Ayman Qasrawi, MD, Gomez Victor, MD, Reinhold Munker, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3847.
https://doi.org/10.1182/blood-2019-123274
Published: 2019
Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Free
Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4096.
https://doi.org/10.1182/blood-2019-122070
Published: 2019
Journal Articles

GSK1838705a, an IGF-1R/ALK Inhibitor, Overcomes Resistance to Crizotinib in ALK-Positive ALCL

Free
Wenyu Shi, Jian-Yong Li, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4069.
https://doi.org/10.1182/blood-2019-130063
Published: 2019
Journal Articles

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Free
Lakshman Vasanthamohan, MD FRCPC, Brent Parker, MD, Joy Mangel, MD FRCPC, Selay Lam, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Chai Wye Phua, MD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 4131.
https://doi.org/10.1182/blood-2019-126997
Published: 2019
Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Free
Denisse A. Castro, MD, Brady E. Beltrán, MD, Luis Villela M, Marialejandra Torres Viera, MD, Victoria Otero, MD, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Christine Rojas, MD, Ivan Perdomo, MD, Pilar León, MD, Karen Lalupu, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, David Gomez-Almaguer, MD, Jose A Hernández-Hernández, PhD, Myrna Candelaria, MDPharmD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Andrés Gómez-De León, MD, Efreen Montaño Figueroa, PhD, Melani Otañez, MD, Carlos Best, MD, Luis E Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4121.
https://doi.org/10.1182/blood-2019-127479
Published: 2019
Journal Articles

Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients - the Diadem Study from the Chronic Malignancies Working Party of the EBMT

Free
Anna Waszczuk-Gajda, MD, Junfeng Wang, PhD, Liesbeth C. de Wreede, PhD, Tiarlan Sirait, MSc, Zubeyde Nur Ozkurt, MD, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Peter Dreger, Árpád Illés, MD D.Sc, Mutlu Arat, MD, Claude-Eric Bulabois, MD, Herrad Baurmann, MD, Matjaz Sever, MD PhD, Grzegorz W Basak, MD PhD Professor, Manos Nikolousis, MD, Victoria Potter, MD PhD, Wilfried Schroyens, MD PhD, Emmanuel Gyan, MD PhD, Gwendolyn Van Gorkom, Javier de la Serna, MD, Blandine Guffroy, Patrick J Hayden, MD, Meral Beksac, MD, Stefan O. Schönland, MD, Ibrahim Yakoub-Agha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4574.
https://doi.org/10.1182/blood-2019-127238
Published: 2019
Journal Articles

Higher Intensity of Cell Surface Glucose-Regulated Protein 78 (csGRP78) Expression Is Seen in Patients with Early Progressive Disease/Mortality in a Cohort of Relapsed, Refractory Multiple Myeloma Patients Treated with Carfilzomib, Thalidomide and Dexamethasone

Free
Slavisa Ninkovic, MBBS FRACP FRCPA, Simon Harrison, MBBS, MRCP, FRCPath, FRACP, PhD, Lenny Straszkowski, BSci Hons, Giulia Quattrocchi, Wee-Joo Chng, MBBS, PhD, Louise E Purton, PhD, Hang Quach, MBBS, FRACP, FRCPA, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4376.
https://doi.org/10.1182/blood-2019-128190
Published: 2019
Journal Articles

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

Free
Keita Tamaki, MD, Satoko Morishima, MD PhD, Shingo Suzuki, PhD, Atsuko Shigenari, Ikumi Nomura, Yutaro Yokota, Kazuho Morichika, MD, Yukiko Nishi, MD PhD, Sawako Nakachi, MD PhD, Shiki Okamoto, PhD, Kennosuke Karube, MD PhD, Takuya Fukushima, MD PhD, Takashi Shiina, PhD, Hiroaki Masuzaki, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2785.
https://doi.org/10.1182/blood-2019-128070
Published: 2019
Journal Articles

NPM1 Quantitative Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia Allows More Precise Selection of Patients for Allogeneic Stem Cell Transplantation without Affecting Their Survival

Free
Yishai Ofran, MD, Ronit Leiba, Dina Rosenberg, Israel Henig, MD, Dana Yehudai-Ofir, MD, Nuhad Haddad, MD, Riva Fineman, MD, Avraham Frisch, MD, Doaa Okasha, MD, Yariv Carasso, MD, Tsila Zuckerman, MD, Nurit Horesh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2603.
https://doi.org/10.1182/blood-2019-126553
Published: 2019
Journal Articles

Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A ( MLL ) Rearrangement

Free
Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Guilin Tang, MD, C. Cameron Yin, MD PhD, Joseph D. Khoury, MD, Ghayas C. Issa, MD, Nitin Jain, MD, Farhad Ravandi, MD, Nicholas J. Short, MD, Courtney D. DiNardo, MDMSc, Koichi Takahashi, MD, Maro Ohanian, DO, Gautam M. Borthakur, MD, Marina Y Konopleva, MD PhD, Naval G. Daver, MD, Zeev E. Estrov, MD, Yesid Alvarado, MD, Alessandra Ferrajoli, MD, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD PhD, Rebecca Garris, MSc, Jorge E. Cortes, MD, Susan O'Brien, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2582.
https://doi.org/10.1182/blood-2019-130864
Published: 2019
Journal Articles

Higher Expression of Nuclear Cereblon in Bone Marrow Biopsies of Patients with Multiple Myeloma Treated with Imids in the HOVON-87/Nmsg-18 Trial Is Associated with Longer PFS and OS

Free
Ruth Wester, M Duin, King Hong Lam, MD PhD, Suzana Couto, Yan Ren, Maria Wang, Bronno Van Der Holt, PhD, Berna Berna Beverloo, PhD, Heleen Visser-Wisselaar, Alex Nigg, Anjan Thakurta, Sonja Zweegman, Annemiek Broyl, MD PhD, Pieter Sonneveld
Journal: Blood
Blood (2019) 134 (Supplement_1): 3071.
https://doi.org/10.1182/blood-2019-128584
Published: 2019